HAYWARD, Calif.--(BUSINESS WIRE)--
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical
company focused on creating innovative cancer immunotherapies, today
announced that Terry Rosen, Ph.D., Chief Executive Officer, will
participate in a fireside chat at the Goldman Sachs 39th
Annual Global Healthcare Conferenceon Tuesday, June 12, 2018at
8:40 am PT at the Terranea Resort, in Rancho Palos Verdes, CA.
Individuals may access the live audio webcast by visiting the “Events &
Presentations” section of the Company’s website at https://investors.arcusbio.com/investors/investor-relations/default.aspx.
A replay of the webcast will be available for 30 days following the live
event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage biopharmaceutical company focused
on creating innovative cancer immunotherapies. Arcus has several
programs targeting important immuno-oncology pathways, including a dual
adenosine receptor antagonist and an anti-PD-1 antibody, both of which
are in Phase 1 trials, as well as a small molecule inhibitor of CD73 and
an anti-TIGIT antibody, which are in IND-enabling studies. Arcus has
extensive in-house expertise in medicinal chemistry, immunology,
biochemistry, pharmacology, and structural biology. For more information
about Arcus Biosciences, please visit www.arcusbio.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180529006103/en/
Arcus Biosciences, Inc.
Jennifer Jarrett, 510-694-6261
jjarrett@arcusbio.com
or
Nicole
Arndt, 510-284-4728
narndt@arcusbio.com
Source: Arcus Biosciences, Inc.